Methanex Corporation (MX)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 89.66 |
|---|---|
| 52-week range | 45.01 – 92.97 |
| Return, 1 month / 3 months | +7.6% / +17.4% |
| Return, 1 year / 3 years | +84.7% / +64.5% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 50.1% |
| Worst drawdown (1 year) | -31.0% |
| Average daily value traded | 19.58M CAD |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Methanex Corporation produces and supplies methanol, a chemical building block made from natural gas. The company operates production sites in several countries and ships methanol to customers around the world. Its customers include chemical manufacturers that use methanol to make other products, as well as fuel blenders and industrial users. Methanex is based in Vancouver, Canada, and its methanol serves industrial markets across Asia, Europe and the Americas.
On this site Methanex Corporation appears as a stock on the Toronto Stock Exchange (Canada), code MX, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Methanex Corporation (MX) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 89.66 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 137 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 84.7% and over the last three months it rose 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.7% | ||
| From 52-week high | -2.5% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 17.4% | ||
| 6-month return | 9.0% | ||
| 12-month return, skipping the last month | 71.6% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.0% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 19.58M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +7.6% |
| 3 months | +17.4% |
| 6 months | +9.0% |
| 1 year | +84.7% |
| 3 years | +64.5% |
| 5 years | +74.8% |
Signals
| 50-day / 200-day average | 84.82 / 77.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Sep 2026 | CAD 0.2580 |
| 16 Jun 2026 | CAD 0.2590 |
| 17 Mar 2026 | CAD 0.2530 |
| 17 Dec 2025 | CAD 0.2540 |
| 16 Sep 2025 | CAD 0.2550 |
| 16 Jun 2025 | CAD 0.2510 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.